GUB-014295

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NameGUB-014295
Drug Alias Namea long-acting amylin analogueGUB-014295GUB014295ABBV-295
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAmylin receptor agonistsAdrenomedullin receptor agonists
TargetsAmylin ReceptorAdrenomedullin receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGubra A/SQuotient Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A